Dengue virus Serotype 3 VLP Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Dengue virus (DENV-3) Serotype 3 VLP protein based upon sequence from: Dengue virus (Strain: Sri Lanka D3/H/IMTSSA-SRI/2000/1266). This VLP protein is combinantion of the C, E1 and E2 sequences. Virus-Like Particles (VLPs) are a new form of protein expression that consist of protein shells with outer proteins that are specific to the given virus. VLPs are immunogenic but are non-infectious, lacking the primary genetic material of the virus. Additionally, VLPs more effectively activate aspects of the immune response, which improves immune stimulation and immunological memory. VLP-based vaccines have also shown to provide effective protection and are in current use for several diseases.
Isolation Country: Sri Lanka
Uniprot Taxonomic Identifier: 11069
Taxonomy: Flaviviridae -> Flavivirus -> Dengue virus
VIPR Database Entry: DENV-3 Strain-Specific Entry
Envelope Protein CDS Start-End:VLP Proteins contain multiple protein sequences. See VIPR entry for more information.
DENV-3 Envelope Protein Sequence: See VLP protein description, above.
Host: QP10481 protein expressed in Human Cells.
Application Notes: Please contact us for application specific information for QP10481.
Purity: >95% as determined by SDS-PAGE.
Reconstitution Instructions:Reconstitute in sterile diH2O. The lyophilate already contains the indicated buffer.
Concentration of Dengue Virus Serotype 3 VLP Protein: Between 0.1-0.8 mg/ml. See CoA for lot-specific concentration.
Endotoxin Levels: Untested
Buffer: 10mM sodium phosphate, 20mM sodium citrate, 154mM sodium chloride, pH7.4.
Storage Conditions: Aliquot and store at -80C.
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.